Literature DB >> 34165686

BoaγPLI from Boa constrictor Blood is a Broad-Spectrum Inhibitor of Venom PLA2 Pathophysiological Actions.

Caroline Fabri Bittencourt Rodrigues1,2,3, Christina N Zdenek1, Caroline Serino-Silva2,3, Karen de Morais-Zani2,3, Kathleen Fernandes Grego2, Melisa Bénard-Valle4, Edgar Neri-Castro4, Alejandro Alagón4, Anita Mitico Tanaka-Azevedo2,3, Bryan Grieg Fry5.   

Abstract

The use of venom in predation exerts a corresponding selection pressure for the evolution of venom resistance. One of the mechanisms related to venom resistance in animals (predators or prey of snakes) is the presence of molecules in the blood that can bind venom toxins, and inhibit their pharmacological effects. One such toxin type are venom phospholipase A2s (PLA2s), which have diverse effects including anticoagulant, myotoxic, and neurotoxic activities. BoaγPLI isolated from the blood of Boa constrictor has been previously shown to inhibit venom PLA2s that induced myotoxic and edematogenic activities. Recently, in addition to its previously described and very potent neurotoxic effect, the venoms of American coral snakes (Micrurus species) have been shown to have anticoagulant activity via PLA2 toxins. As coral snakes eat other snakes as a major part of their diet, neonate Boas could be susceptible to predation by this sympatric species. Thus, this work aimed to ascertain if BoaγPLI provided a protective effect against the anticoagulant toxicity of venom from the model species Micrurus laticollaris in addition to its ability shown previously against other toxin types. Using a STA R Max coagulation analyser robot to measure the effect upon clotting time, and TEG5000 thromboelastographers to measure the effect upon clot strength, we evaluated the ability of BoaγPLI to inhibit M. laticollaris venom. Our results indicate that BoaγPLI is efficient at inhibiting the M. laticollaris anticoagulant effect, reducing the time of coagulation (restoring them closer to non-venom control values) and increasing the clot strength (restoring them closer to non-venom control values). These findings demonstrate that endogenous PLA2 inhibitors in the blood of non-venomous snakes are multi-functional and provide broad resistance against a myriad of venom PLA2-driven toxic effects including coagulotoxicity, myotoxicity, and neurotoxicity. This novel form of resistance could be evidence of selective pressures caused by predation from venomous snakes and stresses the need for field-based research aimed to expand our understanding of the evolutionary dynamics of such chemical arms race.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Anticoagulation; Endogenous inhibitors; PLA2 inhibitor; Venom resistance

Mesh:

Substances:

Year:  2021        PMID: 34165686     DOI: 10.1007/s10886-021-01289-4

Source DB:  PubMed          Journal:  J Chem Ecol        ISSN: 0098-0331            Impact factor:   2.626


  39 in total

1.  A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A(2) inhibitor, displays antitumour activity.

Authors:  Sandra Donnini; Federica Finetti; Simona Francese; Francesca Boscaro; Francesca R Dani; Fabio Maset; Roberta Frasson; Michele Palmieri; Mario Pazzagli; Vincenzo De Filippis; Enrico Garaci; Marina Ziche
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

2.  Rock squirrel (Spermophilus variegatus) blood sera affects proteolytic and hemolytic activities of rattlesnake venoms.

Authors:  James E Biardi; Richard G Coss
Journal:  Toxicon       Date:  2010-12-22       Impact factor: 3.033

3.  Isolation, characterization, cloning and expression of an alpha-neurotoxin from the venom of the Mexican coral snake Micrurus laticollaris (Squamata: Elapidae).

Authors:  Alejandro Carbajal-Saucedo; Estuardo López-Vera; Melisa Bénard-Valle; Eric N Smith; Fernando Zamudio; Adolfo R de Roodt; Alejandro Olvera-Rodríguez
Journal:  Toxicon       Date:  2013-02-22       Impact factor: 3.033

4.  Venom resistance in the hedgehog, Erinaceus europaeus: purification and identification of macroglobulin inhibitors as plasma antihemorrhagic factors.

Authors:  C A de Wit; B R Weström
Journal:  Toxicon       Date:  1987       Impact factor: 3.033

Review 5.  Coevolution takes the sting out of it: Evolutionary biology and mechanisms of toxin resistance in animals.

Authors:  Kevin Arbuckle; Ricardo C Rodríguez de la Vega; Nicholas R Casewell
Journal:  Toxicon       Date:  2017-10-27       Impact factor: 3.033

6.  The binding site of the nicotinic acetylcholine receptor in animal species resistant to alpha-bungarotoxin.

Authors:  D Barchan; M Ovadia; E Kochva; S Fuchs
Journal:  Biochemistry       Date:  1995-07-18       Impact factor: 3.162

7.  Parallel arms races between garter snakes and newts involving tetrodotoxin as the phenotypic interface of coevolution.

Authors:  Edmund D Brodie; Chris R Feldman; Charles T Hanifin; Jeffrey E Motychak; Daniel G Mulcahy; Becky L Williams; Edmund D Brodie
Journal:  J Chem Ecol       Date:  2005-02       Impact factor: 2.626

8.  How the mongoose can fight the snake: the binding site of the mongoose acetylcholine receptor.

Authors:  D Barchan; S Kachalsky; D Neumann; Z Vogel; M Ovadia; E Kochva; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Anticoagulant Micrurus venoms: Targets and neutralization.

Authors:  Daniel Dashevsky; Melisa Bénard-Valle; Edgar Neri-Castro; Nicholas J Youngman; Christina N Zdenek; Alejandro Alagón; José A Portes-Junior; Nathaniel Frank; Bryan G Fry
Journal:  Toxicol Lett       Date:  2020-11-14       Impact factor: 4.372

Review 10.  Endogenous phospholipase A2 inhibitors in snakes: a brief overview.

Authors:  Patrícia Cota Campos; Lutiana Amaral de Melo; Gabriel Latorre Fortes Dias; Consuelo Latorre Fortes-Dias
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2016-12-21
View more
  1 in total

Review 1.  Convergent evolution of toxin resistance in animals.

Authors:  Jory van Thiel; Muzaffar A Khan; Roel M Wouters; Richard J Harris; Nicholas R Casewell; Bryan G Fry; R Manjunatha Kini; Stephen P Mackessy; Freek J Vonk; Wolfgang Wüster; Michael K Richardson
Journal:  Biol Rev Camb Philos Soc       Date:  2022-05-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.